CONMED Corp financial data

Symbol
CNMD on NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
Location
11311 Concept Boulevard, Largo, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 227 % +25.3%
Quick Ratio 119 % +24.2%
Debt-to-equity 154 % -20.3%
Return On Equity 14.6 % +78.9%
Return On Assets 5.75 % +107%
Operating Margin 15.3 % +58.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.9M shares
Entity Public Float 1.6B USD -48.4%
Common Stock, Value, Issued 313K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.8M shares +0.58%
Weighted Average Number of Shares Outstanding, Diluted 31.2M shares -1.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.31B USD +5%
Revenue from Contract with Customer, Excluding Assessed Tax 1.31B USD +5%
Research and Development Expense 54.4M USD +3.47%
Operating Income (Loss) 200M USD +66.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 163M USD +102%
Income Tax Expense (Benefit) 30.6M USD +87%
Net Income (Loss) Attributable to Parent 132M USD +105%
Earnings Per Share, Basic 4.29 USD/shares +104%
Earnings Per Share, Diluted 4.25 USD/shares +108%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 238M USD -1.88%
Inventory, Net 347M USD +8.92%
Assets, Current 640M USD +3.96%
Deferred Income Tax Assets, Net 11.1M USD -1.27%
Property, Plant and Equipment, Net 116M USD -4.08%
Operating Lease, Right-of-Use Asset 39.8M USD +140%
Intangible Assets, Net (Excluding Goodwill) 618M USD -4.9%
Goodwill 805M USD -0.18%
Other Assets, Noncurrent 116M USD +21.1%
Assets 2.31B USD +0.27%
Accounts Payable, Current 102M USD +15.9%
Employee-related Liabilities, Current 65.4M USD -6.71%
Liabilities, Current 278M USD -10.5%
Long-term Debt and Lease Obligation 905M USD -7%
Deferred Income Tax Liabilities, Net 74.1M USD +21.6%
Operating Lease, Liability, Noncurrent 33.3M USD +236%
Other Liabilities, Noncurrent 86.3M USD -28.7%
Liabilities 1.34B USD -8.34%
Accumulated Other Comprehensive Income (Loss), Net of Tax -58.9M USD -17.3%
Retained Earnings (Accumulated Deficit) 560M USD +23.8%
Stockholders' Equity Attributable to Parent 963M USD +15.4%
Liabilities and Equity 2.31B USD +0.27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 29.1M USD
Net Cash Provided by (Used in) Financing Activities -17M USD -418%
Net Cash Provided by (Used in) Investing Activities -2.04M USD +52.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 31.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.56M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.5M USD +0.67%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Operating Lease, Liability 41.4M USD +138%
Depreciation 4.05M USD -0.27%
Payments to Acquire Property, Plant, and Equipment 2.04M USD -52.2%
Lessee, Operating Lease, Liability, to be Paid 51.7M USD +145%
Property, Plant and Equipment, Gross 421M USD +2.02%
Operating Lease, Liability, Current 8.09M USD +7.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.15M USD +65.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.09M USD +7.78%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 1.87M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD +182%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.52M USD +182%
Deferred Tax Assets, Operating Loss Carryforwards 1.7M USD -39.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 1.15M USD -32.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.72M USD +232%
Additional Paid in Capital 477M USD +6.73%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 34.7M USD -1.42%
Deferred Tax Assets, Net of Valuation Allowance 114M USD -5.24%
Interest Expense 37.3M USD -6.23%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%